Nootropic fullerenes and use
AssigneeCarbon 60 (Zhejiang) Pharmaceutical Technology Co., Ltd.
InventorPeter Butzloff
Life of this patent
Estimating the term…
Loading patent…
AssigneeCarbon 60 (Zhejiang) Pharmaceutical Technology Co., Ltd.
InventorPeter Butzloff
Estimating the term…
A dual neurotransmitter nanoparticle composition is provided to store and transport protons and cations across neural cell membranes. This composition mitigates cognitive deficits in neurological pathologies such as autism spectrum disorder and some symptoms of Alzheimer's disease, as well as to reduce the severity of aging related reactive oxygen species damage in ASD and AD brains that are caused by bioenergetic dysfunction. The antioxidant and protein oligomer disassembly properties can also be used to alleviate corneal cataracts. The composition comprises C60 fullerenes bonded to one glutathione molecule and one or more molecules of adenosine triphosphate and can be produced at low temperatures through reactive shear mixing. This composition therapeutically improves and prophylactically preserves cognitive performance, memory, and mental acuity to alleviate deficits arising from bio-electrochemical dysfunction in brain cells.
A method of treating autism spectrum disorders in a subject, comprising the step of:
A method of treating brain dysfunction in Alzheimer's disease in a subject, comprising the step of:
Dependencies are inferred from the claim text.